Shimizu Ichiro, Kawahara Toshiyasu, Haspot Fabienne, Bardwell Philip D, Carroll Michael C, Sykes Megan
Bone Marrow Transplantation Section, Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
Blood. 2007 Feb 15;109(4):1773-81. doi: 10.1182/blood-2006-02-002386. Epub 2006 Oct 5.
B-1b cells produce IgM natural antibodies against alpha1-3Galbeta1-4GlcNAc (alphaGal). These can be tolerized by nonmyeloablative induction of mixed chimerism using alphaGal-positive (alphaGal+) donor marrow. We assessed the role of CR1/2 in this model for induction of tolerance of B-1b cells. Mixed hematopoietic chimerism was induced in alpha1-3galactosyltransferase (GalT-/-) and GalT-/-Cr2-/- mice with alphaGal+ BALB/c marrow donors. Anti-alphaGal Ab and anti-alphaGal Ab-producing B cells became undetectable in GalT-/- chimeras, whereas they persisted in chimeric GalT-/-Cr2-/- mice. To determine whether CR1/2 expression on stromal cells and/or hematopoietic cells was critical for B-1-cell tolerance, we generated GalT-/- radiation chimeras in which CR1/CR2 was expressed on either stromal cells, hematopoietic cells, neither, or both. After induction of mixed chimerism from alphaGal+ allogeneic bone marrow (BM) donors, anti-alphaGal-producing B cells were rendered tolerant in reconstituted recipients expressing only stromal CR1/CR2. Our results suggest a possible role for follicular dendritic cells that pick up immune complexes via CR1/CR2 receptors in the tolerization of B-1b cells.
B-1b细胞产生针对α1-3半乳糖β1-4N-乙酰葡糖胺(αGal)的IgM天然抗体。使用αGal阳性(αGal+)供体骨髓通过非清髓性诱导混合嵌合体可使这些抗体产生耐受。我们评估了补体受体1/2(CR1/2)在该模型中诱导B-1b细胞耐受的作用。用αGal+ BALB/c骨髓供体在α1-3半乳糖基转移酶(GalT-/-)和GalT-/-Cr2-/-小鼠中诱导混合造血嵌合体。在GalT-/-嵌合体中抗αGal抗体和产生抗αGal抗体的B细胞变得无法检测到,而它们在嵌合的GalT-/-Cr2-/-小鼠中持续存在。为了确定基质细胞和/或造血细胞上CR1/2的表达对于B-1细胞耐受是否至关重要,我们构建了GalT-/-辐射嵌合体,其中CR1/CR2在基质细胞、造血细胞、两者均无或两者上表达。在用αGal+同种异体骨髓(BM)供体诱导混合嵌合体后,在仅表达基质CR1/CR2的重建受体中,产生抗αGal的B细胞产生了耐受。我们的结果表明,通过CR1/CR2受体摄取免疫复合物的滤泡树突状细胞在B-1b细胞耐受中可能发挥作用。